Gencrest Bio Products Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 30.00 Cr
as on 16-11-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 60.00 Cr
as on 16-11-2024
- Revenue 14.56%
(FY 2023)
- Profit -27.92%
(FY 2023)
- Ebitda -25.27%
(FY 2023)
- Net Worth 486.48%
(FY 2023)
- Total Assets 58.81%
(FY 2023)
About Gencrest Bio Products
The Corporate was formerly known as Gencrest Bio-Fibre Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 30.00 Cr.
The company currently has active open charges totaling ₹60.00 Cr.
The Key Managerial Personnel (KMP) at Gencrest Bio Products Private Limited India are Shilpa Sharma as COMPANY SECRETARY and Sailesh Pati as Cfo. Purushottam Agrawal, Ravi Agrawal, and Mragank Nema serve as directors at the Company.
- CIN/LLPIN
U17309MH2020PTC340351
- Company No.
340351
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Gencrest Bio Products?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Agrawal  | Managing Director | 06-Jun-2020 | Current |
| Shilpa Sharma | Company Secretary | 06-Sep-2024 | Current |
| Sailesh Pati | CFO | 16-Jan-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Purushottam Agrawal | Director | 06-Jun-2020 | Current |
| Mragank Nema | Director | 13-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Gencrest Bio Products.
Gencrest Bio Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.56% increase. The company also saw a substantial fall in profitability, with a 27.92% decrease in profit. The company's net worth Soared by an impressive increase of 486.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gencrest Bio Products?
In 2023, Gencrest Bio Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Samta Mines And Minerals LimitedActive 6 years 11 monthsPurushottam Agrawal and Ravi Agrawal are mutual person
Samta Energy Private LimitedActive 16 years 11 monthsPurushottam Agrawal and Ravi Agrawal are mutual person
Proto9 Materials Private LimitedActive 2 years 7 monthsPurushottam Agrawal and Ravi Agrawal are mutual person
- Samta Fintech Private LimitedActive 5 years 2 months
Purushottam Agrawal and Ravi Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Jul 2024 | ₹60.00 Cr | Open |
How Many Employees Work at Gencrest Bio Products?
Gencrest Bio Products has a workforce of 115 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gencrest Bio Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gencrest Bio Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
